These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3137237

  • 1. Determination of D,L-threo-3,4-dihydroxyphenylserine and of the D- and L-enantiomers in human plasma and urine.
    Boomsma F, van der Hoorn FA, Man in 't Veld AJ, Schalekamp MA.
    J Chromatogr; 1988 Jun 03; 427(2):219-27. PubMed ID: 3137237
    [Abstract] [Full Text] [Related]

  • 2. d,l-threo-3,4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension in dopamine beta-hydroxylase deficiency.
    Man in 't Veld AJ, Boomsma F, van den Meiracker AH, Julien C, Lenders J, Schalekamp MA.
    J Hypertens Suppl; 1988 Dec 03; 6(4):S547-9. PubMed ID: 3149290
    [Abstract] [Full Text] [Related]

  • 3. Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats.
    Araki H, Tanaka C, Fujiwara H, Nakamura M, Ohmura I.
    J Pharm Pharmacol; 1981 Dec 03; 33(12):772-7. PubMed ID: 6121848
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Synthesis of norepinephrine from 3,4-dihydroxyphenylserine by L-aromatic amino acid decarboxylase of the rat brain and kidneys].
    Fujiwara H, Inagaki C, Ikeda Y, Tanaka C.
    Nihon Yakurigaku Zasshi; 1976 Oct 03; 72(7):891-8. PubMed ID: 14060
    [Abstract] [Full Text] [Related]

  • 6. Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension.
    Lamotte G, Holmes C, Sullivan P, Goldstein DS.
    Clin Auton Res; 2019 Feb 03; 29(1):113-117. PubMed ID: 30229336
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of monoamine oxidase by 3,4-dihydroxyphenylserine.
    Naoi M, Nagatsu T.
    J Neurochem; 1986 Aug 03; 47(2):604-7. PubMed ID: 3090204
    [Abstract] [Full Text] [Related]

  • 9. Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
    Morimoto S, Matsumura Y, Ohyama T, Shinyama H, Ichihara T, Takahashi Y, Hisaki K.
    Jpn J Pharmacol; 1990 Mar 03; 52(3):431-9. PubMed ID: 2110272
    [Abstract] [Full Text] [Related]

  • 10. Treatment of parkinsonism with L-threo-3,4-dihydroxyphenylserine: a pharmacokinetic study.
    Suzuki T, Sakoda S, Ueji M, Kishimoto S, Hayashi A, Kondo T, Narabayashi H.
    Neurology; 1984 Nov 03; 34(11):1446-50. PubMed ID: 6436731
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease.
    Yamamoto M, Ogawa N, Ujike H.
    J Neurol Sci; 1986 Mar 03; 73(1):39-44. PubMed ID: 3084714
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enzymatic decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat heart.
    Ohmura I, Inagaki C, Araki H, Tanaka C.
    Jpn J Pharmacol; 1978 Oct 03; 28(5):747-53. PubMed ID: 31501
    [Abstract] [Full Text] [Related]

  • 16. Treatment of orthostatic hypotension in Shy-Drager syndrome with DL-threo-3,4-dihydroxyphenylserine: a case report.
    Sakoda S, Suzuki T, Higa S, Ueji M, Kishimoto S, Matsumoto M, Yoneda S.
    Eur Neurol; 1985 Oct 03; 24(5):330-4. PubMed ID: 3932074
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome.
    Kachi T, Iwase S, Mano T, Saito M, Kunimoto M, Sobue I.
    Neurology; 1988 Jul 03; 38(7):1091-4. PubMed ID: 3133573
    [Abstract] [Full Text] [Related]

  • 20. Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
    Yamamoto M, Ujike H, Ogawa N.
    Clin Neuropharmacol; 1985 Jul 03; 8(4):334-42. PubMed ID: 2416437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.